The STEPS - Totalis™ Trial
- Conditions
- Lumbar Spinal Stenosis
- Interventions
- Device: TotalisProcedure: Comparator Surgical Procedure
- Registration Number
- NCT02079038
- Lead Sponsor
- VertiFlex, Incorporated
- Brief Summary
The purpose of this study is to determine safety and effectiveness, as measured by changes in pain, disability, patient satisfaction, and claudicatory symptoms, at 6 months following treatment with the Totalis™ Direct Decompression System or Sham Comparator Surgical Procedure in patients with lumbar spinal stenosis
- Detailed Description
Subjects suffering from symptoms of neurogenic intermittent claudication secondary to a radiographically-confirmed diagnosis of central canal stenosis, with or without mild or moderate lateral recess stenosis, at one or two levels from L1 to L5 who meet all inclusion/exclusion criteria, including ≥6 months of non-operative management.
Patients included in the clinical investigation will return for follow-up visits at 1 week for safety evaluation, and at 6 weeks, 3 months, 6 months, 12 months, 18 months and 24 months post-treatment to collect data for evaluation of safety and effectiveness.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 180
- Male or female subjects greater than or equal to 55 years of age
- Neurogenic intermittent claudication (NIC) symptoms defined generally as leg/buttock/ groin pain and/or paresthesias that are exacerbated with standing and walking and relieved by flexion
- VAS leg symptom severity >50 (in either leg) during episodes of neurogenic claudication
- Subjects who are able to walk a minimum of 50 feet without experiencing NIC symptoms
- Diagnosis of central canal spinal stenosis, with or without mild to moderate lateral recess stenosis, at one or two levels from L1-L5 with radiologic evidence
- Subjects with persistent lumbar spinal stenosis symptoms that, during the course of the last year, have been unresponsive to a minimum of 6 months of conservative therapy
- Significant back, buttock or leg pain from causes other than lumbar central canal stenosis
- Axial back pain only
- Severe foraminal stenosis at index level(s) and/or symptomatic foraminal stenosis at any lumbar level
- Severe lateral recess stenosis
- Lumbar spinal stenosis at more than two levels determined pre-operatively to require surgical intervention
- Prior decompressive surgery at index level (s) or fusion at any lumbar level
- Epidural steroid or nerve block steroid injection at index level(s) within 6 weeks of baseline assessments
- Spondylolisthesis (anterolisthesis or retrolisthesis) greater than grade 1
- Spondylolysis (pars fracture)
- Significant degenerative lumbar scoliosis at index level(s)
- Morbid obesity
- Significant peripheral vascular disease
- Active significant co-morbidity
- Undergoing immunosuppressive therapy or long-term steroid use
- Current spinal cord stimulator or implanted pain pump
- Life expectancy less than 2 years
- Evidence of substance abuse within the year
- Involvement or potential involvement in litigation related to the spine or worker's compensation related to a back and/or leg issue
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Totalis™ Direct Decompression Procedure Totalis Totalis Comparator Procedure Comparator Surgical Procedure Comparator Surgical Procedure
- Primary Outcome Measures
Name Time Method Percentage of Subjects With Clinically Significant Improvement in Outcomes Baseline and 6 Months Where clinically significant improvement in outcomes is defined as improvement in any 2 of the 3 domains of the Zurich Claudication Questionnaire ( ZCQ)
* Improvement in physical function by ≥ 0.5 points from baseline
* Improvement in symptom severity by ≥ 0.5 points from baseline
* Patient Satisfaction Score of \< 2.5 points
And no interventions of the following nature through 6 months:
* Re-operations or revisions at index level(s) intended to treat stenosis
* Epidural steroid injection or selective nerve root block at index level(s)
And no unblindings
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (19)
Integrated Pain Management Medical Group, Inc.
🇺🇸Walnut Creek, California, United States
GWU - Medical Faculty Associates, Inc.
🇺🇸Washington, District of Columbia, United States
Arizona Pain Specialists
🇺🇸Scottsdale, Arizona, United States
Performance Spine and Sports Physicians, PC
🇺🇸Pottstown, Pennsylvania, United States
Spine Team Texas
🇺🇸Southlake, Texas, United States
Virginia iSpine Physicians PC
🇺🇸Richmond, Virginia, United States
Florida Pain Institute
🇺🇸Merritt Island, Florida, United States
Pain Management Associates
🇺🇸Independence, Missouri, United States
University Pain Medicine Center
🇺🇸Somerset, New Jersey, United States
Medhat Mikhael, M.D. Inc.
🇺🇸Fountain Valley, California, United States
Holy Cross Hospital
🇺🇸Fort Lauderdale, Florida, United States
Penn State Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States
Alabama Clinical Therapeutics
🇺🇸Birmingham, Alabama, United States
Hope Research Institute
🇺🇸Phoenix, Arizona, United States
Oklahoma Pain Physicians
🇺🇸Oklahoma City, Oklahoma, United States
SC Pain & Spine Specialists
🇺🇸Murrells Inlet, South Carolina, United States
Orthopedic Pain Specialists
🇺🇸Santa Monica, California, United States
American Health Network
🇺🇸Muncie, Indiana, United States
Pain Care, LLC
🇺🇸Stockbridge, Georgia, United States